Pulmonology Advisor Contributing Writer

Thirty-day readmission following hospitalization for pneumonia is common in patients with underlying comorbidities such as COPD, kidney and heart diseases, and dementia.

Macrolide monotherapy may be a better choice than inhaled corticosteroids to prevent acute and hospitalized respiratory infections in older patients with bronchiectasis and without COPD or asthma.

Treating severe community-acquired pneumonia with a combination of corticosteroids and antibiotics may be a cost-effective strategy.

Previous antibiotic use and mechanical invasive ventilation were risk factors for multidrug-resistant pathogens in hospital-associated or ventilator-associated pneumonia.